Caris Life Sciences Statistics
Total Valuation
CAI has a market cap or net worth of $5.05 billion. The enterprise value is $5.39 billion.
| Market Cap | 5.05B |
| Enterprise Value | 5.39B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CAI has 297.11 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 297.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.16 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $255,793 |
| Profits Per Employee | -$209,813 |
| Employee Count | 1,769 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CAI had revenue of $452.50 million and -$371.16 million in losses. Loss per share was -$1.25.
| Revenue | 452.50M |
| Gross Profit | 209.73M |
| Operating Income | -222.85M |
| Pretax Income | -371.16M |
| Net Income | -371.16M |
| EBITDA | -180.12M |
| EBIT | -225.78M |
| Loss Per Share | -$1.25 |
Balance Sheet
The company has $34.93 million in cash and $376.74 million in debt, giving a net cash position of -$341.81 million or -$1.15 per share.
| Cash & Cash Equivalents | 34.93M |
| Total Debt | 376.74M |
| Net Cash | -341.81M |
| Net Cash Per Share | -$1.15 |
| Equity (Book Value) | -2.60B |
| Book Value Per Share | -8.75 |
| Working Capital | 8.68M |
Cash Flow
In the last 12 months, operating cash flow was -$202.61 million and capital expenditures -$9.40 million, giving a free cash flow of -$212.01 million.
| Operating Cash Flow | -202.61M |
| Capital Expenditures | -9.40M |
| Free Cash Flow | -212.01M |
| FCF Per Share | -$0.71 |
Margins
Gross margin is 46.35%, with operating and profit margins of -49.25% and -82.02%.
| Gross Margin | 46.35% |
| Operating Margin | -49.25% |
| Pretax Margin | -82.02% |
| Profit Margin | -82.02% |
| EBITDA Margin | -39.81% |
| EBIT Margin | -49.90% |
| FCF Margin | -46.85% |
Dividends & Yields
CAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -7.35% |
| FCF Yield | -4.20% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |